Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Duke University School of Medicine, Durham, North Carolina, USA.
Nutr Rev. 2021 Jan 1;79(1):98-113. doi: 10.1093/nutrit/nuaa085.
Caloric restriction (CR) is a strategy that attenuates aging in multiple nonhuman species. The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) trials are part of a research program aiming to test the effects of CR on aging and longevity biomarkers in humans. Building on CALERIE phase 1, CALERIE phase 2 (CALERIE 2) was the largest study to date to assess sustained CR in healthy humans without obesity. In a 24-month randomized controlled trial comprising 218 participants at baseline, CALERIE 2 showed that moderate CR, 11.9% on average, induced improvements in aging-related biomarkers without adversely affecting psychological or behavioral outcomes. The objectives of this report are to summarize and review the highlights of CALERIE 2 and report previously unpublished results on eating disorder symptoms and cognitive function. This article specifically summarizes the physiological, psychological, aging, behavioral, and safety results of the trial. Also provided are research directions beyond CALERIE 2 that highlight important opportunities to investigate the role of CR in aging, longevity, and health span in humans.
热量限制(CR)是一种在多种非人类物种中减缓衰老的策略。全面评估减少能量摄入对衰老的长期影响(CALERIE)试验是一项旨在测试 CR 对人类衰老和长寿生物标志物影响的研究计划的一部分。基于 CALERIE 阶段 1,CALERIE 阶段 2(CALERIE 2)是迄今为止评估健康人群中持续 CR 的最大研究,这些人群没有肥胖。在一项由 218 名参与者组成的为期 24 个月的随机对照试验中,CALERIE 2 表明,平均 11.9%的适度 CR 可改善与衰老相关的生物标志物,而不会对心理或行为结果产生不利影响。本报告的目的是总结和回顾 CALERIE 2 的要点,并报告以前未发表的关于饮食失调症状和认知功能的结果。本文特别总结了试验的生理、心理、衰老、行为和安全性结果。此外,还提供了超越 CALERIE 2 的研究方向,强调了研究 CR 在人类衰老、长寿和健康跨度中的作用的重要机会。